Current Drug Safety, Volume 8 - Number 2

Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate

, 8(2): 77 - 97

Oliver Pohl, Philip W. Harvey, Sean McKeag, Scott E. Boley and Jean-Pierre Gotteland

DOI: 10.2174/15748863112079990012

Pattern of Medication Use Among Older Inpatients in Seven Hospitals in Italy: Results from the Criteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) Project

, 8(2): 98 - 103

Matteo Tosato, Silvana Settanni, Manuela Antocicco, Miriam Battaglia, Andrea Corsonello, Carmelinda Ruggiero, Stefano Volpato, Paolo Fabbietti, Fabrizia Lattanzio, Roberto Bernabei and Graziano Onder

DOI: 10.2174/1574886311308020002

The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?

, 8(2): 104 - 113

Izyan A. Wahab, Nicole L. Pratt, Lisa M. Kalisch and Elizabeth E. Roughead

DOI: 10.2174/15748863113089990030

A Comparison of Adverse Drug Reactions Between High- and Standard- Dose Trimethoprim-Sulfamethoxazole in the Ambulatory Setting

, 8(2): 114 - 119

Ann T. Nguyen, Chris A. Gentry and Rona Z. Furrh

DOI: 10.2174/1574886311308020004

Testosterone Use in Women: How Safe is it?

, 8(2): 120 - 127

Robert S. Tan and Seng-Hin Teoh

DOI: 10.2174/1574886311308020005

Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens

, 8(2): 128 - 140

Sonia Chaabane and Anick Berard

DOI: 10.2174/15748863112079990011

Acute Fulminant Hepatatis in Kidney Transplant Recipient After Repeated Sevoflurane Anesthesia - A Case Report and Literature Review

, 8(2): 141 - 144

Jelka Masin-Spasovska, Koco Dimitrovski, Sotir Stavridis, Oliver Stankov, Saso Dohcev, Skender Saidi, Krume Jakovski, Trajan Balkanov, Nikola Labacevski, Viktor Stankov, Ljupco Lekovski and Goce Spasovski

DOI: 10.2174/15748863113089990026

Cefpodoxime Proxetil-Related Hemolysis and Acute Interstitial Nephritis

, 8(2): 145 - 147

Hakki Yilmaz, Mukadder Ayse Bilgic, Nuket Bavbek and Ali Akcay

DOI: 10.2174/15748863113089990028

Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma

, 8(2): 148 - 152

Andreas Holstein, Peter Kovacs and Winfried Beil

DOI: 10.2174/15748863113089990027

Webmaster Contact:
Copyright © 2018 Bentham Science